Women's Health: A Primary Care Clinical
Guide Advanced Prep: Master Chapters 1-25
Practice Questions & Detailed Explanations
Subject: Comprehensive Women's Health (Chapters 1-25)
Question 1: A 28-year-old female presents for a preconception counseling visit. She has a history
of polycystic ovary syndrome (PCOS) and is currently taking metformin. She is concerned about
the impact of her condition on future pregnancy. Which of the following is the most critical
recommendation regarding her metabolic health and pregnancy outcomes?
A) Immediately discontinue metformin, as it is contraindicated during conception and the first
trimester.
B) Maintain current metformin dosage and initiate high-dose folic acid (4 mg daily) due to
potential folate absorption interference.
C) Transition to glyburide, as it is the gold standard for glycemic control in PCOS patients
during the preconception period.
D) Focus exclusively on weight reduction through intensive caloric restriction to normalize
ovulatory function before conception.
Correct Answer: B) Maintain current metformin dosage and initiate high-dose folic acid (4
mg daily) due to potential folate absorption interference.
Explanation: Metformin is increasingly used in the preconception and early pregnancy period
for women with PCOS to reduce the risk of gestational diabetes and miscarriage. A significant
clinical consideration is that long-term metformin use is associated with a decrease in vitamin
B12 and folate levels. Therefore, supplementing with higher doses of folic acid is a evidence-
based precaution. Discontinuing the medication abruptly without cause is not recommended, and
weight loss, while beneficial, is not the sole priority over glycemic and nutritional management.
Question 2: A 45-year-old patient presents with abnormal uterine bleeding (AUB). An
endometrial biopsy reveals simple hyperplasia without atypia. Given current clinical guidelines
for primary care, what is the most appropriate next step in management?
A) Immediate total hysterectomy to prevent progression to adenocarcinoma.
B) Cyclic progestin therapy or placement of a levonorgestrel-releasing intrauterine system
(LNG-IUS).
C) High-dose systemic estrogen replacement to stabilize the endometrium.
,D) Serial Dilation and Curettage (D&C) every 3 months until histology returns to normal.
Correct Answer: B) Cyclic progestin therapy or placement of a levonorgestrel-releasing
intrauterine system (LNG-IUS).
Explanation: Simple hyperplasia without atypia is a benign process caused by unopposed
estrogen. The first-line treatment is progestin therapy to induce secretory changes and sloughing
of the endometrium, or the use of an LNG-IUS, which provides high local concentrations of
progestin. Hysterectomy is reserved for cases that progress to atypical hyperplasia or cancer, or
for patients who fail conservative management. Systemic estrogen is contraindicated as it would
exacerbate the hyperplasia.
Question 3: A 34-year-old woman presents with persistent, pruritic, white, thin, "cigarette-paper"
appearing skin on the vulva and perineum. She reports dyspareunia and difficulty with defecation
due to fissures. What is the definitive diagnostic approach and first-line treatment?
A) Punch biopsy to rule out squamous cell carcinoma; topical high-potency corticosteroids.
B) KOH preparation to rule out candidiasis; topical antifungal cream.
C) Clinical diagnosis based on appearance; surgical excision of the affected area.
D) Serum hormone panel to check for lichenified estrogen deficiency; systemic hormone
replacement.
Correct Answer: A) Punch biopsy to rule out squamous cell carcinoma; topical high-potency
corticosteroids.
Explanation: The description is classic for Lichen Sclerosus. Because this condition has a
documented risk of transformation into squamous cell carcinoma (SCC), a biopsy is mandatory
for diagnosis. The standard of care for treatment is high-potency topical corticosteroids (e.g.,
clobetasol propionate) to manage inflammation and prevent architectural changes like scarring
and resorption of the labia.
Question 4: In a patient with primary dysmenorrhea, prostaglandins play a central role. Which
mechanism best explains the efficacy of NSAIDs in this patient population?
A) Inhibition of cyclooxygenase (COX) enzymes, leading to decreased prostaglandin synthesis
and reduced uterine hypercontractility.
B) Direct relaxation of the uterine smooth muscle via calcium channel blockade.
C) Suppression of endometrial proliferation through estrogen receptor modulation.
D) Elevation of the pain threshold by interacting with opioid receptors in the pelvic plexus.
,Correct Answer: A) Inhibition of cyclooxygenase (COX) enzymes, leading to decreased
prostaglandin synthesis and reduced uterine hypercontractility.
Explanation: Primary dysmenorrhea is largely driven by high levels of prostaglandins
(specifically PGF2α) in the menstrual fluid, which cause uterine contractions and ischemia.
NSAIDs are potent inhibitors of the COX enzyme, which is the rate-limiting step in prostaglandin
production. By reducing the concentration of these mediators, NSAIDs effectively mitigate
uterine cramping.
Question 5: A 22-year-old female presents with symptoms of bacterial vaginosis (BV). She asks
if her male partner needs to be treated to prevent recurrent infections. According to current
evidence-based guidelines for primary care, what is the best advice?
A) Treat the partner with oral metronidazole 500 mg BID for 7 days.
B) Treat the partner with oral clindamycin only if he is symptomatic.
C) Inform the patient that partner treatment is not recommended, as clinical trials have not shown
it to be effective in preventing recurrence.
D) Recommend the partner use a barrier method and undergo testing for urethritis.
Correct Answer: C) Inform the patient that partner treatment is not recommended, as
clinical trials have not shown it to be effective in preventing recurrence.
Explanation: Bacterial Vaginosis is characterized by a shift in the vaginal microbiome (loss of
lactobacilli, overgrowth of anaerobes). Despite the sexual nature of many social interactions, BV
is not classified as a classic sexually transmitted infection (STI). Multiple randomized clinical
trials have demonstrated that treating male partners does not reduce the incidence of recurrence
in the index patient.
Question 6: When screening for intimate partner violence (IPV) in a primary care setting, which
approach is most effective for uncovering hidden abuse?
A) Using a mandatory screening tool for all patients regardless of the presenting complaint.
B) Only asking if the patient appears disheveled or has visible bruising.
C) Asking the patient directly in the presence of their spouse to ensure transparency.
D) Avoiding the topic unless the patient volunteers information, to preserve the provider-patient
trust.
Correct Answer: A) Using a mandatory screening tool for all patients regardless of the
presenting complaint.
, Explanation: Universal screening is the clinical standard for IPV because many survivors will
not self-disclose unless asked directly in a safe, private, and standardized manner. Physical signs
of abuse are often absent. Asking in the presence of a partner is dangerous and violates patient
confidentiality and safety, as it may escalate violence.
Question 7: A 52-year-old postmenopausal woman presents with vaginal dryness and
dyspareunia. She has a history of estrogen-receptor-positive breast cancer treated 3 years ago.
Which management strategy is most appropriate?
A) Systemic Hormone Replacement Therapy (HRT) with low-dose estrogen.
B) Non-hormonal vaginal moisturizers and lubricants as first-line therapy.
C) Vaginal estrogen tablets, which are completely absorbed and pose a high risk for breast
cancer recurrence.
D) DHEA (Prasterone) inserts, which act as a potent systemic estrogen agonist.
Correct Answer: B) Non-hormonal vaginal moisturizers and lubricants as first-line therapy.
Explanation: For patients with a history of hormone-sensitive cancers, non-hormonal options are
the first line for genitourinary syndrome of menopause (GSM). While low-dose vaginal estrogen
is sometimes considered in collaboration with an oncologist, non-hormonal lubricants and
moisturizers provide symptomatic relief without the risk of systemic hormone exposure.
Question 8: A patient presents with nipple discharge. Which clinical feature is most concerning
for an underlying malignancy?
A) Bilateral, milky discharge in a non-lactating woman.
B) Bilateral, yellow-green discharge associated with fibrocystic changes.
C) Unilateral, spontaneous, bloody discharge from a single duct.
D) Bilateral, clear discharge that occurs only upon nipple stimulation.
Correct Answer: C) Unilateral, spontaneous, bloody discharge from a single duct.
Explanation: Pathologic nipple discharge—specifically spontaneous, unilateral, and bloody—
requires immediate workup (imaging and biopsy) to rule out intraductal papilloma or breast
cancer. Bilateral and multi-ductal discharge is more often physiologic or related to hormonal
changes.
Question 9: A 30-year-old woman requests information on long-acting reversible contraception
(LARC). She has a history of deep vein thrombosis (DVT). Which of the following is the best
recommendation?
Guide Advanced Prep: Master Chapters 1-25
Practice Questions & Detailed Explanations
Subject: Comprehensive Women's Health (Chapters 1-25)
Question 1: A 28-year-old female presents for a preconception counseling visit. She has a history
of polycystic ovary syndrome (PCOS) and is currently taking metformin. She is concerned about
the impact of her condition on future pregnancy. Which of the following is the most critical
recommendation regarding her metabolic health and pregnancy outcomes?
A) Immediately discontinue metformin, as it is contraindicated during conception and the first
trimester.
B) Maintain current metformin dosage and initiate high-dose folic acid (4 mg daily) due to
potential folate absorption interference.
C) Transition to glyburide, as it is the gold standard for glycemic control in PCOS patients
during the preconception period.
D) Focus exclusively on weight reduction through intensive caloric restriction to normalize
ovulatory function before conception.
Correct Answer: B) Maintain current metformin dosage and initiate high-dose folic acid (4
mg daily) due to potential folate absorption interference.
Explanation: Metformin is increasingly used in the preconception and early pregnancy period
for women with PCOS to reduce the risk of gestational diabetes and miscarriage. A significant
clinical consideration is that long-term metformin use is associated with a decrease in vitamin
B12 and folate levels. Therefore, supplementing with higher doses of folic acid is a evidence-
based precaution. Discontinuing the medication abruptly without cause is not recommended, and
weight loss, while beneficial, is not the sole priority over glycemic and nutritional management.
Question 2: A 45-year-old patient presents with abnormal uterine bleeding (AUB). An
endometrial biopsy reveals simple hyperplasia without atypia. Given current clinical guidelines
for primary care, what is the most appropriate next step in management?
A) Immediate total hysterectomy to prevent progression to adenocarcinoma.
B) Cyclic progestin therapy or placement of a levonorgestrel-releasing intrauterine system
(LNG-IUS).
C) High-dose systemic estrogen replacement to stabilize the endometrium.
,D) Serial Dilation and Curettage (D&C) every 3 months until histology returns to normal.
Correct Answer: B) Cyclic progestin therapy or placement of a levonorgestrel-releasing
intrauterine system (LNG-IUS).
Explanation: Simple hyperplasia without atypia is a benign process caused by unopposed
estrogen. The first-line treatment is progestin therapy to induce secretory changes and sloughing
of the endometrium, or the use of an LNG-IUS, which provides high local concentrations of
progestin. Hysterectomy is reserved for cases that progress to atypical hyperplasia or cancer, or
for patients who fail conservative management. Systemic estrogen is contraindicated as it would
exacerbate the hyperplasia.
Question 3: A 34-year-old woman presents with persistent, pruritic, white, thin, "cigarette-paper"
appearing skin on the vulva and perineum. She reports dyspareunia and difficulty with defecation
due to fissures. What is the definitive diagnostic approach and first-line treatment?
A) Punch biopsy to rule out squamous cell carcinoma; topical high-potency corticosteroids.
B) KOH preparation to rule out candidiasis; topical antifungal cream.
C) Clinical diagnosis based on appearance; surgical excision of the affected area.
D) Serum hormone panel to check for lichenified estrogen deficiency; systemic hormone
replacement.
Correct Answer: A) Punch biopsy to rule out squamous cell carcinoma; topical high-potency
corticosteroids.
Explanation: The description is classic for Lichen Sclerosus. Because this condition has a
documented risk of transformation into squamous cell carcinoma (SCC), a biopsy is mandatory
for diagnosis. The standard of care for treatment is high-potency topical corticosteroids (e.g.,
clobetasol propionate) to manage inflammation and prevent architectural changes like scarring
and resorption of the labia.
Question 4: In a patient with primary dysmenorrhea, prostaglandins play a central role. Which
mechanism best explains the efficacy of NSAIDs in this patient population?
A) Inhibition of cyclooxygenase (COX) enzymes, leading to decreased prostaglandin synthesis
and reduced uterine hypercontractility.
B) Direct relaxation of the uterine smooth muscle via calcium channel blockade.
C) Suppression of endometrial proliferation through estrogen receptor modulation.
D) Elevation of the pain threshold by interacting with opioid receptors in the pelvic plexus.
,Correct Answer: A) Inhibition of cyclooxygenase (COX) enzymes, leading to decreased
prostaglandin synthesis and reduced uterine hypercontractility.
Explanation: Primary dysmenorrhea is largely driven by high levels of prostaglandins
(specifically PGF2α) in the menstrual fluid, which cause uterine contractions and ischemia.
NSAIDs are potent inhibitors of the COX enzyme, which is the rate-limiting step in prostaglandin
production. By reducing the concentration of these mediators, NSAIDs effectively mitigate
uterine cramping.
Question 5: A 22-year-old female presents with symptoms of bacterial vaginosis (BV). She asks
if her male partner needs to be treated to prevent recurrent infections. According to current
evidence-based guidelines for primary care, what is the best advice?
A) Treat the partner with oral metronidazole 500 mg BID for 7 days.
B) Treat the partner with oral clindamycin only if he is symptomatic.
C) Inform the patient that partner treatment is not recommended, as clinical trials have not shown
it to be effective in preventing recurrence.
D) Recommend the partner use a barrier method and undergo testing for urethritis.
Correct Answer: C) Inform the patient that partner treatment is not recommended, as
clinical trials have not shown it to be effective in preventing recurrence.
Explanation: Bacterial Vaginosis is characterized by a shift in the vaginal microbiome (loss of
lactobacilli, overgrowth of anaerobes). Despite the sexual nature of many social interactions, BV
is not classified as a classic sexually transmitted infection (STI). Multiple randomized clinical
trials have demonstrated that treating male partners does not reduce the incidence of recurrence
in the index patient.
Question 6: When screening for intimate partner violence (IPV) in a primary care setting, which
approach is most effective for uncovering hidden abuse?
A) Using a mandatory screening tool for all patients regardless of the presenting complaint.
B) Only asking if the patient appears disheveled or has visible bruising.
C) Asking the patient directly in the presence of their spouse to ensure transparency.
D) Avoiding the topic unless the patient volunteers information, to preserve the provider-patient
trust.
Correct Answer: A) Using a mandatory screening tool for all patients regardless of the
presenting complaint.
, Explanation: Universal screening is the clinical standard for IPV because many survivors will
not self-disclose unless asked directly in a safe, private, and standardized manner. Physical signs
of abuse are often absent. Asking in the presence of a partner is dangerous and violates patient
confidentiality and safety, as it may escalate violence.
Question 7: A 52-year-old postmenopausal woman presents with vaginal dryness and
dyspareunia. She has a history of estrogen-receptor-positive breast cancer treated 3 years ago.
Which management strategy is most appropriate?
A) Systemic Hormone Replacement Therapy (HRT) with low-dose estrogen.
B) Non-hormonal vaginal moisturizers and lubricants as first-line therapy.
C) Vaginal estrogen tablets, which are completely absorbed and pose a high risk for breast
cancer recurrence.
D) DHEA (Prasterone) inserts, which act as a potent systemic estrogen agonist.
Correct Answer: B) Non-hormonal vaginal moisturizers and lubricants as first-line therapy.
Explanation: For patients with a history of hormone-sensitive cancers, non-hormonal options are
the first line for genitourinary syndrome of menopause (GSM). While low-dose vaginal estrogen
is sometimes considered in collaboration with an oncologist, non-hormonal lubricants and
moisturizers provide symptomatic relief without the risk of systemic hormone exposure.
Question 8: A patient presents with nipple discharge. Which clinical feature is most concerning
for an underlying malignancy?
A) Bilateral, milky discharge in a non-lactating woman.
B) Bilateral, yellow-green discharge associated with fibrocystic changes.
C) Unilateral, spontaneous, bloody discharge from a single duct.
D) Bilateral, clear discharge that occurs only upon nipple stimulation.
Correct Answer: C) Unilateral, spontaneous, bloody discharge from a single duct.
Explanation: Pathologic nipple discharge—specifically spontaneous, unilateral, and bloody—
requires immediate workup (imaging and biopsy) to rule out intraductal papilloma or breast
cancer. Bilateral and multi-ductal discharge is more often physiologic or related to hormonal
changes.
Question 9: A 30-year-old woman requests information on long-acting reversible contraception
(LARC). She has a history of deep vein thrombosis (DVT). Which of the following is the best
recommendation?
